Smoking Cessation, the most cost effective intervention for the most preventable mortality and morbidity burden

S. Belo Ravara (Covilhã, Portugal)

Source: International Congress 2017 – Hot topic on tobacco prevention and cessation
Session: Hot topic on tobacco prevention and cessation
Session type: Hot topics
Number: 1749
Disease area: Airway diseases

WebcastSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Belo Ravara (Covilhã, Portugal). Smoking Cessation, the most cost effective intervention for the most preventable mortality and morbidity burden. International Congress 2017 – Hot topic on tobacco prevention and cessation

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Changes in COPD-related morbidity and mortality after smoking cessation: a review
Source: Annual Congress 2007 - Environmental and clinical aspects of COPD
Year: 2007


COPD-related morbidity and mortality after smoking cessation: status of the evidence
Source: Eur Respir J 2008; 32: 844-853
Year: 2008



Smoking attributable mortality in Portugal
Source: Eur Respir J 2007; 30: Suppl. 51, 639s
Year: 2007

Gender differences in mortality risks in relation to smoking in a long-term follow-up of the Malmö preventive project
Source: Eur Respir J 2003; 22: Suppl. 45, 111s
Year: 2003

Asthma exacerbations during pregnancy increase risk of adverse perinatal outcomes
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020




Contribution of respiratory disease and smoking to in-hospital mortality
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015


Rapid reduction in hospitalisations after an intervention to manage severe asthma
Source: Eur Respir J 2010; 35: 515-521
Year: 2010



Success rate of a trans-disciplinary in-hospital smoking cessation program
Source: Annual Congress 2013 –Smoking cessation
Year: 2013

Pharmacological treatment, mortality and hospitalisations
Source: Annual Congress 2004 - Pharmacoepidemiology of obstructive lung disease: beyond clinical trials
Year: 2004

Reducing childhood respiratory morbidity and mortality in low and middle income countries: a current challenge
Source: Eur Respir J, 54 (1) 1900987; 10.1183/13993003.00987-2019
Year: 2019



Impact of climate change on ozone-related mortality and morbidity in Europe
Source: Eur Respir J 2013; 41: 285-294
Year: 2013



Successful use of a ²bottom up² strategy to reduce acute asthma morbidity during childhood
Source: Eur Respir J 2006; 28: Suppl. 50, 481s
Year: 2006

Annual budgetary impact of varenicline as part of a smoking cessation strategy in Greece
Source: International Congress 2015 – Emerging data on (e-)cigarettes and their health hazards
Year: 2015

Impact of intermittent hypoxia on cardiovascular morbidity and mortality
Source: Research Seminar 2005 - Adaptations to Hypoxia
Year: 2005


Quitting smoking and reduction of cardiovascular risk factors
Source: International Congress 2016 – Smoking-related diseases
Year: 2016


Smoking prevalence and mortality in Europe
Source: Annual Congress 2006 - Tobacco control in Europe: what are the priorities?
Year: 2006